Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Cheng

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|July 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical careJingyao Ma, Chang Cui, Juntao Ouyang, et al.
British Journal of Haematology|February 16, 2024
Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in ChinaZhifa Wang, Aijun Zhang, Zhongjin Xu, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2025
A real-world study of sirolimus in the treatment of pediatric head and neck lymphatic malformationsJialu Wang, Yiran Meng, Xuexi Zhang, et al.
Pediatric Investigation|June 24, 2024
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mLZhengping Li, Jie Sun, Zekun Li, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2025
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort studyJingyao Ma, Zhifa Wang, Juntao Ouyang, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|February 2, 2013
Association between sex hormone levels and abnormal metabolism in a population of elderly Chinese menYanping Gong, Haiying Xiao, Jie Bai, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
(+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolismJin Zhang, Lin Jia, Xiya Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2025
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencingZekun Li, Yongqiang Tang, Zhenping Chen, et al.
The Laryngoscope|February 11, 2021
Efficacy of Initial Sirolimus Therapy for 27 Patients with Intractable Lymphatic MalformationsXuexi Zhang, Shengcai Wang, Yongli Guo, et al.
Haematologica|May 7, 2026
Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopeniaJingyao Ma, Zhenping Chen, Xiaoling Cheng, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|July 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical careJingyao Ma, Chang Cui, Juntao Ouyang, et al.
British Journal of Haematology|February 16, 2024
Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in ChinaZhifa Wang, Aijun Zhang, Zhongjin Xu, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2025
A real-world study of sirolimus in the treatment of pediatric head and neck lymphatic malformationsJialu Wang, Yiran Meng, Xuexi Zhang, et al.
Pediatric Investigation|June 24, 2024
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mLZhengping Li, Jie Sun, Zekun Li, et al.
Research and Practice in Thrombosis and Haemostasis|December 11, 2025
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort studyJingyao Ma, Zhifa Wang, Juntao Ouyang, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|February 2, 2013
Association between sex hormone levels and abnormal metabolism in a population of elderly Chinese menYanping Gong, Haiying Xiao, Jie Bai, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
(+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolismJin Zhang, Lin Jia, Xiya Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2025
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencingZekun Li, Yongqiang Tang, Zhenping Chen, et al.
The Laryngoscope|February 11, 2021
Efficacy of Initial Sirolimus Therapy for 27 Patients with Intractable Lymphatic MalformationsXuexi Zhang, Shengcai Wang, Yongli Guo, et al.
Haematologica|May 7, 2026
Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopeniaJingyao Ma, Zhenping Chen, Xiaoling Cheng, et al.
Pageof 15